OOIR: Observatory of International Research

Papers

(The H4-Index of Gut is 73. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Unusual history of ‘stitch’	2211
Response to McAlindon’s letter	1336
Innumerable nodules in all parts of the small intestine	612
Immunomodulation and entry inhibition: selgantolimod’s double punch against hepatitis B virus	518
Correction: P97 A patient information bundle outlining dietary advice in liver disease specific to the cost of living crisis improves patient care: ‘Looking after Your Liver for	343
Real-world evidence supports earlier treatment in HBeAg-positive but not HBeAg-negative chronic hepatitis B virus infection	339
Refining intergenerational MASLD risk: are measurement and mediation shaping the signal?	322
Picking up microbial clues in early-onset colorectal cancer	282
Reassessing the prophylactic effect of clip closure to prevent delayed rebleeding after colorectal endoscopic submucosal dissection	270
Preclinical stages of Crohn’s disease defined by faecal calprotectin in asymptomatic first-degree relatives: screening framework for prevention trials	261
Recent advances in our understanding of the gut microbiome: an analysis from the Gut Microbiota for Health Expert Panel of the British Society of Gastroenterology	245
A mucus production programme promotes classical pancreatic ductal adenocarcinoma	240
IL-3 receptor signalling suppresses chronic intestinal inflammation by controlling mechanobiology and tissue egress of regulatory T cells	237
Liquid biopsy to identify Barrett’s oesophagus, dysplasia and oesophageal adenocarcinoma: the EMERALD multicentre study	223
Holistic healthcare in inflammatory bowel disease: time for patient-centric approaches?	217
Establishment of enterically transmitted hepatitis virus animal models using lipid nanoparticle-based full-length viral genome RNA delivery system	194
Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation	177
Absence of a pancreatic microbiome in intraductal papillary mucinous neoplasm	171
Effect of long-term adherence on faecal immunochemical test positivity rate, positive predictive value and detection rate in organised population-based colorectal cancer screening	153
Mass cytometry-based peripheral blood analysis as a novel tool for early detection of solid tumours: a multicentre study	148
Growth rates and histopathological outcomes of small (6–9 mm) colorectal polyps based on CT colonography surveillance and endoscopic removal	148
Crohn’s disease and ulcerative colitis exhibit prediagnostic antibody signatures with shared and divergent changes towards disease onset	146
Impact of margin thermal ablation after endoscopic mucosal resection of large (≥20 mm) non-pedunculated colonic polyps on long-term recurrence	144
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis B	143
Rate of suitable cases for primary EUS-guided biliary drainage in distal malignant biliary obstruction	143

S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos	142
Where are we with gastric cancer screening in Europe in 2024?	140
Hepatocyte senescence in alcohol-associated hepatitis: epiphenomenon or disease-driving mechanism?	138
Third Asia-Pacific consensus recommendations on colorectal cancer screening and postpolypectomy surveillance	134
Perturbation of mRNA splicing in liver cancer: insights, opportunities and challenges	133
Rare cause of obstructive jaundice	133
Time for arginine methylation: PRMT5 inhibition to advance cholangiocarcinoma treatment	132
Selective decontamination of the digestive tract in critically ill children: fighting fire with fire or burning down the house?	132
Steatosis severity and metabolic fingerprints after HCV eradication: toward an individualised approach to HCC surveillance after HCV cure	132
Limitations of Helicobacter pylori single-method testing: evidence from a cohort study	128
Correction: Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism	127
Most excess years of potential life loss among individuals with cirrhosis during the pandemic were not related to COVID-19	124
Impact of climate change on vulnerable populations	123
Endoscopic mucosal and submucosal cutting for long benign oesophageal strictures	122
Reflux conditions induce E-cadherin cleavage and EMT via APE1 redox function in oesophageal adenocarcinoma	120
Need for standardised approaches to human microbiome research using the example of colorectal neoplasia research	119
Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and adaptive resistance in pancreatic cancer	115
Tumour-intrinsic alterations and stromal matrix remodelling promote Wnt-niche independence during diffuse-type gastric cancer progression	110
Definite benefits of GLP-1 receptor agonists: what is the risk of gastroparesis and lung aspiration?	110
New entity of adult ultra-short coeliac disease: the first international cohort and case–control study	106
Decoding HBV-specific adaptive immunity: from natural clearance to cure	103
Hypothesis-generating evaluation of multi-armoured oncolytic HSV-1 (VG161) in intrahepatic cholangiocarcinoma: pooled insights from multicentre studies	101
Large-scale multiomic analysis identifies non-coding somatic driver mutations and nominates ZFP36L2 as a driver gene for pancreatic ductal adenocarcinoma	97
Gastrointestinal microbiota and inflammasomes interplay in health and disease: a gut feeling	95
Engineered anti-PDL1 with IFNα targets both immunoinhibitory and activating signals in the liver to break HBV immune tolerance	93
Perplexing case of abdominal pain with eosinophilia and fasciitis	92
Unveiling 8 years of duodenoscope contamination: insights from a retrospective analysis in a large tertiary care hospital	92
British Society of Gastroenterology guidelines on sedation in gastrointestinal endoscopy	91
Association between appendectomy and Parkinson’s disease from the UK Biobank	89
Intron-mediated enhancement of SPINK1 expression for pancreatitis therapy	88
Combination therapies for metabolic dysfunction-associated steatohepatitis: challenges and opportunities	86
Integrated multimodel analysis of intestinal inflammation exposes key molecular features of preclinical and clinical IBD	83
Quantifying artificial sweeteners and emulsifiers in Crohn’s disease and its relationship with disease activity: the ENIGMA study – a novel and targeted approach	83
MicroRNA-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression	82
Asian Pacific Association of Gastroenterology task force recommendations on surveillance for Helicobacter pylori associated gastric premalignant conditio	81
24-Nor-ursodeoxycholic acid improves intestinal inflammation by targeting T _H 17 pathogenicity and transdifferentiation	81
Endoscopic stratification of gastric intestinal metaplasia: where are we, where do we want to go and how do we get there?	81
A20-mediated KEAP1 ubiquitination orchestrates hepatocyte ferroptosis to ameliorate autoimmune hepatitis	80
Serum creatinine as both yardstick and predictor: reading chronic kidney disease in the global CLEARED cohort	80
Targeting hepatic stellate cells to combat liver fibrosis: where do we stand?	79
SMYD2-mediated methylation of STAT1 protects against hepatic ischaemia/reperfusion injury by blocking JAK-STAT1 signalling pathways	79
Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8 ⁺ T cells	78
Does the benefit of haemostatic powder differ by Forrest classification in non-variceal upper gastrointestinal bleeding?	78
Ebastine for the treatment of irritable bowel syndrome: old drug, new tricks?	78
GI highlights from the literature	77
Correction: Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysis	75
Correction: Revisiting the role of sphincterotomy in sphincter of oddi disorder: a critical appraisal of the RESPOnD study	74
British Society of Gastroenterology interim framework for addressing the COVID-19-related backlog in inflammatory bowel disease colorectal cancer surveillance	73
APCmosaicism, not always isolated: two first-degree relatives with apparently distinctAPCmosaicism	73